Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc (CNTA) Stock Overview

Explore Centessa Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

CNTA●NASDAQ
HealthcareBiotechnology
$40.50
$0.00(0.00%)
U.S. Market opens in 63h 23m

Centessa Pharmaceuticals plc (CNTA)

Meyka AI Score

Z

Key Financials

Market Cap6.3B
P/E Ratio-22.75
EPS (TTM)$-1.79
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$43.99
3 Months$57.57
1 Year Target$44.16

CNTA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Centessa Pharmaceuticals plc (NASDAQ: CNTA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Centessa Pharmaceuticals plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CNTA on the NASDAQ shows an RSI of 79.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $44.16 for the NASDAQ listing.

Key metrics behind Centessa Pharmaceuticals plc's NASDAQ-traded stock include a P/E ratio of -22.75 and a market capitalization of 6.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CNTA on the NASDAQ.

Price Performance (NASDAQ: CNTA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.61%
6-Month Change
60.27%
Year-to-Date (YTD) Change
61.94%
1-Year Change
161.63%
3-Year Change
500.89%
5-Year Change
92.49%
All-Time (Max) Change
86.21%

Contact Information

https://www.centessa.com
44 203 9206789
1 Ashley Road, Altrincham, NaN, WA14 2DT

Company Facts

1,290 Employees
IPO DateMay 28, 2021
CountryGB

Frequently Asked Questions